pteridines has been researched along with poloxin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shin, SB; Woo, SU; Yim, H | 1 |
Friemel, A; Kreis, NN; Louwen, F; Ritter, A; Yuan, J | 1 |
2 other study(ies) available for pteridines and poloxin
Article | Year |
---|---|
Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Benzimidazoles; Benzoates; Benzoquinones; Binding Sites; Catalytic Domain; Cell Cycle Proteins; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Design; Female; G2 Phase Cell Cycle Checkpoints; HeLa Cells; Humans; Inhibitory Concentration 50; Mitosis; Molecular Targeted Therapy; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Pteridines; Quinones; S Phase Cell Cycle Checkpoints; Signal Transduction; Thiophenes; Time Factors; Uterine Cervical Neoplasms | 2015 |
Impact of Polo-like kinase 1 inhibitors on human adipose tissue-derived mesenchymal stem cells.
Topics: Adipose Tissue; Adult; Apoptosis; Benzoates; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Cellular Senescence; Female; Humans; MCF-7 Cells; Mesenchymal Stem Cells; Mitosis; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Quinones | 2016 |